September 24, 2021Open Access

Short-acting β2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

This study indicates an association between high SABA prescriptions and poor clinical outcomes across a broad range of countries, healthcare settings and asthma severities, providing support for initiatives to improve asthma morbidity by reducing SABA overreliance.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Bateman et al. (Fri,) studied this question.

synapsesocial.com/papers/69e5da6ddb3f836d8f13c508 https://doi.org/https://doi.org/10.1183/13993003.01402-2021

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Role of community pharmacists in asthma - Australian research highlighting pathways for future primary care models.2011 · 26 citations
2Role of community pharmacists in asthma – Australian research highlighting pathways for future primary care models2011 · 33 citations
3Management of asthma at private pharmacies in India.2006 · 28 citations
4Taking Aim at Asthma Around the World: Global Results of the Asthma Insight and Management Survey in the Asia-Pacific Region, Latin America, Europe, Canada, and the United States2015 · 80 citations
5Rescue Use of Beclomethasone and Albuterol in a Single Inhaler for Mild Asthma2007 · 368 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo